Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety, Tolerability & Immunogenicity of the Recombinant Plague Vaccine rF1V
This study has been completed.
Study NCT00097396   Information provided by DynPort Vaccine Company LLC, A CSC Company
First Received: November 23, 2004   Last Updated: September 25, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pneumonic Plague
Preventive Therapy
Additional conditions recognized in this trial
Plague
More general conditions related to this trial
Bacterial Infections
Enterobacteriaceae Infections
Gram-Negative Bacterial Infections
Yersinia Infections
Interventions listed in this trial
rF1V vaccine
Sponsors listed in this trial
DynPort Vaccine Company LLC, A CSC Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services